Robotic Placement ENvue has launched ENvue Drive, a robotic-assisted tool for automatically placing feeding tubes, indicating a move toward automation and efficiency in enteral care that can reduce clinician workload and improve placement accuracy—a compelling upsell to hospitals and home care providers seeking advanced delivery.

OTC Distribution The company expanded into over-the-counter reusable ENFit syringes nationwide through non-acute care channels via a distribution agreement with U Deliver, creating a new revenue stream and opportunities to cross-sell enteral care products to clinics, home health suppliers, and durable medical equipment distributors.

Strategic Leadership New board leadership with a named chairman and ongoing R&D in Tel-Aviv alongside U.S. commercial leadership signals a strategic push to accelerate product development and market penetration, presenting a fertile environment for enterprise customers seeking cutting-edge enteral solutions and long-term partnerships.

Acquisition Context The acquisition by NanoVibronix in early 2025 suggests potential integration with broader non-invasive therapeutics platforms and cross-sell opportunities into NanoVibronix’s customer base, as well as potential partnerships or co-marketing with a larger medical technology ecosystem.

Growth Signals Revenue range and ongoing fundraising indicate a growth phase with scalable products and expanding distribution; prospective buyers and distributors can explore multi-location deployments, channel partnerships, and bundled offerings that combine ENvue’s enteral care platform with related home care and device solutions.